We are live on ! Find out more
BCAM

Boston Common Asset Management Portfolio holdings

AUM $1.69B
1-Year Est. Return 28.29%
This Fund
S&P 500
This Quarter Est. Return
+12.26%
1 Year Est. Return
+28.29%
3 Year Est. Return
+54.94%
5 Year Est. Return
+54.02%
10 Year Est. Return
+260.31%
AUM
$2.09B
AUM Growth
+$183M
Cap. Flow
-$44.1M
Cap. Flow %
-2.11%
Top 10 Hldgs %
19.96%
Holding
269
New
13
Increased
109
Reduced
125
Closed
11

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$16.7M
2
MET icon
MetLife
MET
+$6.65M
3
MKC icon
McCormick & Company Non-Voting
MKC
+$5.02M
4
ED icon
Consolidated Edison
ED
+$4.78M
5
TJX icon
TJX Companies
TJX
+$2.62M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$20.8M
2
LOW icon
Lowe's Companies
LOW
+$7.88M
3
ENPH icon
Enphase Energy
ENPH
+$6.85M
4
HAS icon
Hasbro
HAS
+$6.13M
5
WRK
WestRock Company
WRK
+$4.83M

Sector Composition

Rank Sector Weight
1 Healthcare 19.86%
2 Financials 15.77%
3 Technology 15.73%
4 Industrials 11.06%
5 Consumer Staples 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
126
Eli Lilly
LLY
$1.06T
$1.03M 0.05%
2,825
+66
+2% +$23.4K
ABBV icon
127
AbbVie
ABBV
$431B
$1.02M 0.05%
6,333
+153
+2% +$23.5K
JPM icon
128
JPMorgan Chase
JPM
$947B
$973K 0.05%
7,257
-4,357
-38% -$552K
BAC icon
129
Bank of America
BAC
$441B
$935K 0.04%
28,225
+583
+2% +$20.1K
COP icon
130
ConocoPhillips
COP
$142B
$877K 0.04%
7,431
-232
-3% -$28.2K
RDY icon
131
Dr. Reddy's Laboratories
RDY
$10.1B
$867K 0.04%
83,765
– –
TMO icon
132
Thermo Fisher Scientific
TMO
$214B
$861K 0.04%
1,564
-66
-4% -$35K
CSCO icon
133
Cisco
CSCO
$477B
$818K 0.04%
17,162
+301
+2% +$13.7K
TLK icon
134
Telkom Indonesia
TLK
$14.7B
$806K 0.04%
33,805
+23,206
+219% +$603K
NEE icon
135
NextEra Energy
NEE
$176B
$803K 0.04%
9,604
+176
+2% +$14.2K
FISV
136
Fiserv Inc
FISV
$28.9B
$694K 0.03%
6,864
-499
-7% -$49.7K
ABT icon
137
Abbott
ABT
$187B
$687K 0.03%
6,259
+137
+2% +$14.2K
DIS icon
138
Walt Disney
DIS
$182B
$672K 0.03%
7,735
+99
+1% +$9.47K
CVX icon
139
Chevron
CVX
$371B
$664K 0.03%
3,700
-2,100
-36% -$366K
SCM
140
DELISTED
SWISSCOM AG ADS(RP 1/10 REG SH
SCM
$623K 0.03%
11,372
+456
+4% +$25K
CVS icon
141
CVS Health
CVS
$123B
$614K 0.03%
6,594
-887
-12% -$85.6K
UNP icon
142
Union Pacific
UNP
$176B
$610K 0.03%
2,947
+38
+1% +$7.79K
LIN icon
143
Linde
LIN
$226B
$580K 0.03%
1,779
+36
+2% +$11.3K
PM icon
144
Philip Morris
PM
$293B
$562K 0.03%
5,550
+132
+2% +$12.5K
BMY icon
145
Bristol-Myers Squibb
BMY
$131B
$549K 0.03%
7,632
+169
+2% +$12.7K
TXN icon
146
Texas Instruments
TXN
$254B
$539K 0.03%
3,263
+68
+2% +$11.3K
NKE icon
147
Nike
NKE
$62.3B
$529K 0.03%
4,521
+102
+2% +$10.3K
BDX icon
148
Becton Dickinson
BDX
$48.8B
$515K 0.02%
2,024
+25
+1% +$5.9K
HLN icon
149
Haleon
HLN
$44.3B
$514K 0.02%
64,260
-124
-0.2% -$844
AJG icon
150
Arthur J. Gallagher & Co
AJG
$64.5B
$507K 0.02%
2,690
-75
-3% -$14K
4 5
6
7 8

Similar funds

GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return

Boston Common Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Boston Common Asset Management held 269 positions worth $2.09B, up 9.6% from $1.91B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Common Asset Management's Q4 2022 filing shows 13 new, 109 increased, 125 reduced and 11 closed positions. Its largest new stake was Quest Diagnostics: 116,092 shares worth $18.2M. The largest sale was TSMC, an estimated $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • Boston Common Asset Management's largest Q4 2022 buy was Quest Diagnostics: 116,092 shares worth $18.2M.
  • Boston Common Asset Management added most to MetLife in Q4 2022, an estimated $6.65M increase.
  • Boston Common Asset Management's biggest Q4 2022 reduction was TSMC, cutting an estimated $20.8M.
  • Boston Common Asset Management fully exited Hasbro in Q4 2022, selling an estimated $6.13M.
  • Boston Common Asset Management's ten largest holdings make up 20% of its $2.09B portfolio in Q4 2022.
  • Boston Common Asset Management opened 13 new positions and closed 11 in Q4 2022.
  • Boston Common Asset Management's portfolio value rose 9.6% quarter-over-quarter to $2.09B.

Based on Boston Common Asset Management's 13F filing for Q4 2022, filed 26 Jan 2023.